India · Delayed Price · Currency is INR Nath Bio-Genes (India) Statistics
Total Valuation
NSE:NATHBIOGEN has a market cap or net worth of INR 3.03 billion. The enterprise value is 3.65 billion.
| Market Cap | 3.03B |
| Enterprise Value | 3.65B |
Important Dates
The last earnings date was Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
NSE:NATHBIOGEN has 19.00 million shares outstanding. The number of shares has increased by 4.21% in one year.
| Current Share Class | 19.00M |
| Shares Outstanding | 19.00M |
| Shares Change (YoY) | +4.21% |
| Shares Change (QoQ) | -15.02% |
| Owned by Insiders (%) | 10.76% |
| Owned by Institutions (%) | 2.23% |
| Float | 6.05M |
Valuation Ratios
The trailing PE ratio is 6.92.
| PE Ratio | 6.92 |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 8.00 |
| EV / Sales | 0.75 |
| EV / EBITDA | 6.26 |
| EV / EBIT | 6.72 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 2.37 |
| Debt / FCF | -8.89 |
| Interest Coverage | 3.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.62% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 9.52% |
| Revenue Per Employee | 10.86M |
| Profits Per Employee | 1.01M |
| Employee Count | 451 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:NATHBIOGEN has paid 47.34 million in taxes.
| Income Tax | 47.34M |
| Effective Tax Rate | 9.40% |
Stock Price Statistics
The stock price has decreased by -12.02% in the last 52 weeks. The beta is 0.82, so NSE:NATHBIOGEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -12.02% |
| 50-Day Moving Average | 166.60 |
| 200-Day Moving Average | 158.80 |
| Relative Strength Index (RSI) | 44.48 |
| Average Volume (20 Days) | 15,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NATHBIOGEN had revenue of INR 4.90 billion and earned 456.11 million in profits. Earnings per share was 22.99.
| Revenue | 4.90B |
| Gross Profit | 2.63B |
| Operating Income | 543.11M |
| Pretax Income | 503.45M |
| Net Income | 456.11M |
| EBITDA | 583.21M |
| EBIT | 543.11M |
| Earnings Per Share (EPS) | 22.99 |
Balance Sheet
The company has 759.95 million in cash and 1.39 billion in debt, with a net cash position of -625.06 million or -32.89 per share.
| Cash & Cash Equivalents | 759.95M |
| Total Debt | 1.39B |
| Net Cash | -625.06M |
| Net Cash Per Share | -32.89 |
| Equity (Book Value) | 6.80B |
| Book Value Per Share | 304.35 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -125.73 million and capital expenditures -30.05 million, giving a free cash flow of -155.78 million.
| Operating Cash Flow | -125.73M |
| Capital Expenditures | -30.05M |
| Depreciation & Amortization | 40.10M |
| Net Borrowing | 160.01M |
| Free Cash Flow | -155.78M |
| FCF Per Share | -8.20 |
Margins
Gross margin is 53.76%, with operating and profit margins of 11.09% and 9.31%.
| Gross Margin | 53.76% |
| Operating Margin | 11.09% |
| Pretax Margin | 10.28% |
| Profit Margin | 9.31% |
| EBITDA Margin | 11.91% |
| EBIT Margin | 11.09% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.24%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 1.24% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.21% |
| Shareholder Yield | -2.97% |
| Earnings Yield | 15.08% |
| FCF Yield | -5.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |